Projects per year
Search results
-
Active
Home Visits are the Answer for Homebound Patients with Amyotrophic Lateral Sclerosis
Greene, E. P. (PI) & Liao, B. (Key Personnel)
5/9/24 → …
Project: Clinical Trial
-
Collaborative Remote Physical Examination: Transforming Medical and Nursing Practice
Greene, E. P. (PI)
9/1/23 → 8/31/26
Project: Federal Funding Agencies
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix D - For pridopidine 45 mg oral capsule administered twice daily (BID) or its matching placebo.
Appel, S. H. (PI), Shroff, S. (PI), Greene, E. P. (CoI) & Liao, B. (CoI)
6/29/21 → 7/23/25
Project: Non Profit
-
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies
Greene, E. P. (PI), Liao, B. (Key Personnel) & Shroff, S. (Key Personnel)
6/28/21 → …
Project: Clinical Trial
-
A Study of Biological Markers for the Nervous and Immune Systems and Free Radical Mediated Processes in Amyotrophic Lateral Sclerosis (ALS)
Appel, S. H. (PI), Beers, D. (Key Personnel), Greene, E. P. (Key Personnel), Lai, E. C. (Key Personnel), Liao, B. (Key Personnel), Shroff, S. (Key Personnel) & Zhao, W. (Key Personnel)
8/13/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix A - For 0.3mh/kg SC zilucoplan administered once daily and placebo
Appel, S. H. (PI), Shroff, S. (PI), Greene, E. P. (CoI) & Liao, B. (CoI)
7/24/20 → 7/23/25
Project: Non Profit
-
Massachusetts General Hospital Healey Center for ALS - Healey ALS Platform Trial
Appel, S. H. (PI), Shroff, S. (PI) & Greene, E. P. (CoI)
7/24/20 → 7/23/25
Project: Non Profit
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix C - For CNM-Au8
Appel, S. H. (PI), Shroff, S. (PI), Greene, E. P. (CoI) & Liao, B. (CoI)
7/24/20 → 7/23/25
Project: Non Profit
-
HEALEY ALS Platform Trial - Regimen-Specific Appendix B - For verdiperstat (also known as BHV-3241)
Appel, S. H. (PI), Shroff, S. (PI), Greene, E. P. (CoI) & Liao, B. (CoI)
7/24/20 → 7/23/25
Project: Non Profit
-
Myotonic Dystrophy Compilation of Clinical Findings
Greene, E. P. (PI), Appel, S. H. (Key Personnel), Ashizawa, T. (Key Personnel), Mathuria, N. (Key Personnel) & Shroff, S. (Key Personnel)
4/1/20 → …
Project: Clinical Trial
-
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1: END-DM1
Greene, E. P. (PI) & Shroff, S. (Key Personnel)
10/8/19 → …
Project: Clinical Trial
-
Neuromuscular Observational Research (MOVR) Data Hub Protocol
Greene, E. P. (PI), Appel, S. H. (Key Personnel) & Shroff, S. (Key Personnel)
5/17/19 → …
Project: Clinical Trial
-
A prospective, multi-center, observational study of the safety, tolerability and effectiveness of SPINRAZA in adult patients with Spinal Muscular Atrophy
Greene, E. P. (CoI) & Shroff, S. (CoI)
4/26/19 → 4/25/44
Project: Non Profit
-
Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety ofOral Fingolimod in Patients with ALS
Greene, E. P. (PI), Appel, S. H. (CoI) & Lai, E. C. (CoI)
Massachusetts General Hospital
5/13/13 → 5/12/38
Project: Non Profit
-
Multicenter Screening Trial of Safety and Efficacy of Lithium Carbonate in ALS (MDA 105838)
Greene, E. P. (PI)
California Pacific Medical Ctr Res Inst
3/1/08 → 7/17/35
Project: Non Profit
-
Not started
A prospective, multi-center, observational study of the safety, tolerability and effectiveness of SPINRAZA in adult patients with Spinal Muscular Atr
Liao, B. (PI), Greene, E. P. (Key Personnel) & Shroff, S. (Key Personnel)
Project: Clinical Trial
-
Genomic Translation for ALS Clinical Care
Appel, S. H. (PI), Greene, E. P. (Key Personnel) & Shroff, S. (Key Personnel)
Project: Clinical Trial
-
COMPILATIONS OF CLINICAL FINDINGS IN AMYOTROPHIC LATERAL SCLEROSIS
Appel, S. H. (PI), Greene, E. P. (Key Personnel), Liao, B. (Key Personnel) & Shroff, S. (Key Personnel)
Project: Clinical Trial
-
Finished
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal)
Greene, E. P. (PI)
9/15/22 → 2/28/24
Project: Federal Funding Agencies
-
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Greene, E. P. (PI)
11/8/18 → 8/31/22
Project: Federal Funding Agencies
-
Myotonic Dystrophy Clinical Research Network (DMCRN) Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1 (DM1)
Greene, E. P. (PI)
6/1/18 → 11/30/22
Project: Non Profit
-
Genomic Translation for ALS Care
Appel, S. H. (PI), Greene, E. P. (CoI) & Shroff, S. (CoI)
10/1/15 → 9/30/19
Project: Non Profit
-
CD4+ CD25+ regulatory T cells as Potential Biomarkers of Pathogenesis and Response to Therapy in CIDP Patients
Greene, E. P. (PI), Appel, S. H. (Project Director) & Lai, E. C. (Project Director)
GBS/CIDP Foundation International
8/22/12 → 6/30/14
Project: Non Profit
-
Clinically Meaningful Changes (CMC) Scale in dthe MDA/ALS Clinical Network
Greene, E. P. (PI)
5/28/10 → 6/30/11
Project: Non Profit
-
Trial of High fat/High Calory Diet versus Optimal Nutrition in Amyotrophic Lateral Sclerosis
Greene, E. P. (PI)
Massachusetts General Hospital
12/8/09 → 6/30/13
Project: Non Profit
-
ALS Research Group (ALSRG) Collection of Data and Biomaterial for Repoistory Banking
Greene, E. P. (PI)
Massachusetts General Hospital
12/1/05 → 11/30/06
Project: Federal Funding Agencies
-
Clinical Trial of Ceftriaxone in Subjects with ALS
Greene, E. P. (PI)
Massachusetts General Hospital
12/1/05 → 12/31/14
Project: Federal Funding Agencies